News Center
Antitumor drugs Bortezomib 179324-69-7
【Catalog number】AP0100
【CAS #】 179324-69-7
【Molecular formula】 C19H25BN4O4
【Molecular Weight】384.24
Alias |
[(1R) -3-methyl-1-[[((2S) -1-oxo-3-phenyl-2-[(pyrazinyl) amino] propyl] amino] butyl] -boronic acid; Patzomi |
Catalog Number |
AP0100 |
CAS # |
179324-69-7 |
Molecular Formula |
C19H25BN4O4 |
Molecular Weight |
384.24 |
Structural Formula |
|
Product Introduction CAS 179324-69-7 US-DMF No. 22884 |
Bortezomib, the English name is Bortezomib, and the American Chemical Abstracts Registration Number is cas179324-69-7. Bortezomib (cas 179324-69-7) is a reversible inhibitor of 26S proteasome chymotrypsin-like activity in mammalian cells. In vitro tests have proven that bortezomib is cytotoxic to many types of cancer cells. Preclinical tumor model in vivo tests have demonstrated that bortezomib can delay tumor growth, including multiple myeloma. This product is used for the treatment of patients with multiple myeloma, and its effectiveness is based on its effectiveness. |
VIWIT 沪ICP备12014533号-2